JP2015536947A5 - - Google Patents

Download PDF

Info

Publication number
JP2015536947A5
JP2015536947A5 JP2015540764A JP2015540764A JP2015536947A5 JP 2015536947 A5 JP2015536947 A5 JP 2015536947A5 JP 2015540764 A JP2015540764 A JP 2015540764A JP 2015540764 A JP2015540764 A JP 2015540764A JP 2015536947 A5 JP2015536947 A5 JP 2015536947A5
Authority
JP
Japan
Prior art keywords
alkyl
acceptable salt
pharmaceutically acceptable
compound according
ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015540764A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015536947A (ja
JP6482466B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/067673 external-priority patent/WO2014070978A1/en
Publication of JP2015536947A publication Critical patent/JP2015536947A/ja
Publication of JP2015536947A5 publication Critical patent/JP2015536947A5/ja
Application granted granted Critical
Publication of JP6482466B2 publication Critical patent/JP6482466B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015540764A 2012-11-03 2013-10-31 サイトメガロウイルスの阻害剤 Active JP6482466B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261722151P 2012-11-03 2012-11-03
US61/722,151 2012-11-03
PCT/US2013/067673 WO2014070978A1 (en) 2012-11-03 2013-10-31 Inhibitors of cytomegalovirus

Publications (3)

Publication Number Publication Date
JP2015536947A JP2015536947A (ja) 2015-12-24
JP2015536947A5 true JP2015536947A5 (enExample) 2016-12-15
JP6482466B2 JP6482466B2 (ja) 2019-03-13

Family

ID=49620280

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015540764A Active JP6482466B2 (ja) 2012-11-03 2013-10-31 サイトメガロウイルスの阻害剤

Country Status (4)

Country Link
US (1) US9284310B2 (enExample)
EP (1) EP2914591B1 (enExample)
JP (1) JP6482466B2 (enExample)
WO (1) WO2014070978A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2988306A1 (en) 2015-06-05 2016-12-08 Vertex Pharmaceuticals Incorporated Triazoles for the treatment of demyelinating diseases
KR102467347B1 (ko) 2016-04-15 2022-11-14 바이엘 애니멀 헬스 게엠베하 피라졸로피리미딘 유도체
CN111448194A (zh) * 2017-12-04 2020-07-24 拜耳作物科学股份公司 3-氨基-[1,2,4]-三唑衍生物及其用于防治不希望的植物生长的用途
CN108003062B (zh) * 2017-12-25 2020-08-11 常州吉恩药业有限公司 一种单boc保护双氨基化合物的合成方法
AU2019339777B2 (en) 2018-09-12 2022-09-01 Novartis Ag Antiviral pyridopyrazinedione compounds
AR118243A1 (es) 2019-03-07 2021-09-22 Pi Industries Ltd Compuestos heterocíclicos fusionados y su uso como agentes de control de plagas
AR119140A1 (es) 2019-06-13 2021-11-24 Pi Industries Ltd Compuestos heterocíclicos fusionados y su uso como agentes de control de plagas
JP7573289B2 (ja) * 2019-06-25 2024-10-25 マイクロバイオティックス, インク. フィロシクロビルによる眼感染症を治療または予防するための組成物および方法
WO2021033141A1 (en) 2019-08-20 2021-02-25 Pi Industries Ltd. Fused heterocyclic compounds and their use as pest control agents
US11667613B2 (en) 2019-09-26 2023-06-06 Novartis Ag Antiviral pyrazolopyridinone compounds
AR121344A1 (es) 2020-02-18 2022-05-11 Pi Industries Ltd Compuestos heterocíclicos fusionados y su uso como agentes para el control de plagas
TWI904906B (zh) 2020-08-24 2025-11-11 美商達薩瑪治療公司 Sarm1之抑制劑
WO2022208370A1 (en) 2021-03-31 2022-10-06 Pi Industries Ltd. Fused heterocyclic compounds and their use as pest control agents
JP2025513455A (ja) 2022-04-22 2025-04-24 バーテックス ファーマシューティカルズ インコーポレイテッド 疼痛の治療のためのヘテロアリール化合物
PY2513474A (es) 2024-02-23 2025-10-10 Pi Industries Ltd Compuestos heterocíclicos fusionados y usos de los mismos

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2353900A (en) 1998-12-09 2000-06-26 Wyeth Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing a substituted phenylenediamine group
CN1348446A (zh) 1998-12-09 2002-05-08 美国家庭用品有限公司 含苯二胺基团的含杂环羧酰胺的疱疹病毒硫脲抑制剂
US6166028A (en) * 1998-12-09 2000-12-26 American Home Products Corporation Diaminopuridine-containing thiourea inhibitors of herpes viruses
CZ20011957A3 (cs) * 1998-12-09 2001-10-17 American Home Products Corporation Thiomočoviny jako inhibitory herpes virů
DE50204780D1 (de) 2001-04-19 2005-12-08 Bayer Healthcare Ag Arylsulfonamide als antivirale mittel
EP2172460A1 (en) 2002-11-01 2010-04-07 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of JAK and other protein kinases
SE0203654D0 (sv) * 2002-12-09 2002-12-09 Astrazeneca Ab New compounds
WO2004071426A2 (en) 2003-02-11 2004-08-26 Kemia Inc. Compounds for the treatment of viral infection
US20090196912A1 (en) 2004-07-30 2009-08-06 Gpc Botech Ag Pyridinylamines
MX2007015679A (es) 2005-06-30 2008-02-21 Amgen Inc Inhibidores de quinasa bis-aril y su uso en el tratamiento de inflamacion, angiogenesis y cancer.
US20090069288A1 (en) 2007-07-16 2009-03-12 Breinlinger Eric C Novel therapeutic compounds
WO2010029300A1 (en) 2008-09-12 2010-03-18 Biolipox Ab Bis aromatic compounds for use in the treatment of inflammation
EP2177521A1 (en) 2008-10-14 2010-04-21 Almirall, S.A. New 2-Amidothiadiazole Derivatives
WO2010077582A1 (en) 2008-12-16 2010-07-08 Merck Sharp & Dohme Corp. Triazole derivatives for treatment of alzheimer's disease
JP2013530199A (ja) 2010-07-06 2013-07-25 ノバルティス アーゲー キナーゼ阻害剤として有用な環状エーテル化合物

Similar Documents

Publication Publication Date Title
JP2016503403A5 (enExample)
JP2014520767A5 (enExample)
JP2018533593A5 (enExample)
JP2019501125A5 (enExample)
JP2016505614A5 (enExample)
JP2013544860A5 (enExample)
JP2015500843A5 (enExample)
JP2016516043A5 (enExample)
JP2012092103A5 (enExample)
JP2013523614A5 (enExample)
JP2014508811A5 (enExample)
JP2017501237A5 (enExample)
JP2015504081A5 (enExample)
JP2016503052A5 (enExample)
JP2012506389A5 (enExample)
JP2013537203A5 (enExample)
JP2014526533A5 (enExample)
JP2015522650A5 (enExample)
RU2013108348A (ru) Конденсированные гетероарилы и их применение
JP2014513051A5 (enExample)
JP2017517565A5 (enExample)
JP2015500842A5 (enExample)
JP2014500296A5 (enExample)
JP2017537937A5 (enExample)
RU2016151420A (ru) Новое терапевтическое применение производных бензилиденгуанидина для лечения протеинопатий